Scientists study immune cells to build better therapies for autoimmune diseases
NCT ID NCT04838171
First seen Jan 21, 2026 · Last updated May 20, 2026 · Updated 19 times
Summary
This study collects and analyzes white blood cells from healthy volunteers and patients with autoimmune diseases, inflammation, or liver transplant. The goal is to understand these cells better so researchers can design engineered regulatory T cell (Treg) therapies. The study does not test any treatment on participants—it only uses donated blood samples for research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Quell Investigator Site 01
RECRUITINGLondon, United Kingdom
Conditions
Explore the condition pages connected to this study.